Fresolimumab and Radiotherapy in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Fresolimumab

RADIATION

Radiation Therapy

Trial Locations (2)

10016

New York University Langone Medical Center Cancer Center, New York

90095-1714

David Geffen School of Medicine at UCLA, Los Angeles

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT01401062 - Fresolimumab and Radiotherapy in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter